A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
Authors:
- C. PozzoCPC. Pozzo
- F. CognettiFCF. Cognetti
- G. GruiaGGG. Gruia
- C. CoteCCC. Cote
Open Access
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (11) , 1199-1204
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) studyAnnals of Oncology, 1998
- Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.Journal of Clinical Oncology, 1997
- Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.Journal of Clinical Oncology, 1997
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.Journal of Clinical Oncology, 1996
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1995
- Chemotherapy for Colorectal CancerNew England Journal of Medicine, 1994
- Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.Journal of Clinical Oncology, 1993
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.Journal of Clinical Oncology, 1992
- Reporting results of cancer treatmentCancer, 1981